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Abstract 
The diagnosis of myocarditis traditionally relies on invasive endomyocardial biopsy but none of the 
imaging studies so far are specific for infiltration of the inflammatory cells itself. We synthesized 
68Ga-2-(p-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) mannosylated 
human serum albumin (MSA) by conjugating human serum albumin with mannose, followed by 
conjugation with NOTA and labeling it with 68Ga. The efficacy of 68Ga-NOTA-MSA positron emission 
tomography (PET) for imaging myocardial inflammation was tested in a rat myocarditis model. A 
significant number of mannose receptor-positive inflammatory cells infiltrated the myocardium in both 
human and rat myocarditis tissue. 68Ga-NOTA-MSA uptake was upregulated in organs of macrophage 
accumulation, such as liver, spleen, bone marrow and myocardium (0.32 (0.31~0.33) for normal versus 
1.02 (0.86~1.06) for myocarditis (median (range), SUV); n=4~6 per group, p-value=0.01). 
68Ga-NOTA-MSA uptake in the left ventricle was upregulated in myocarditis compared with normal 
rats (2.29 (1.42~3.40) for normal versus 4.18 (3.43~6.15) for myocarditis (median (range), average 
standard uptake value ratio against paraspinal muscle); n=6 per group, p-value<0.01), which was 
downregulated in rats with cyclosporine-A treated myocarditis (3.69 (2.59~3.86) for myocarditis versus 
2.28 (1.76~2.60) for cyclosporine-A treated myocarditis; n=6 per group, p-value<0.01). The specificity 
of the tracer was verified by administration of excess non-labeled MSA. 68Ga-NOTA-MSA uptake was 
significantly enhanced earlier in the evolution of myocarditis before any signs of inflammation could be 
seen on echocardiography. These results demonstrate the potential utility of visualizing infiltration of 
mannose receptor-positive macrophages with 68Ga-NOTA-MSA PET in the early diagnosis of as well as 
in the monitoring of treatment response of myocarditis. 
Key words: myocarditis, macrophage, mannose receptor, positron emission tomography, molecular imaging.  
Introduction 
Myocarditis is a condition defined as a 
pathological immune response in the myocardium by 
noxious stimuli and is characterized by massive 
infiltration of immune cells, especially macrophages 
(1). Clinically, myocarditis can lead to sudden death 
or acute heart failure and in the long term, chronic 
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dilated cardiomyopathy (2). Therefore, the proper 
diagnosis is important in patients with suspected 
myocarditis.  
The traditional gold standard method of 
diagnosing myocarditis has been to prove the active 
inflammation of the myocardium with 
endomyocardial biopsy (3), supported by biochemical 
evidence of active myocardial damage (4), and by 
visualizing indirect evidence of myocardial 
inflammation, such as myocardial edema on various 
imaging studies (5). However, none of these are 
specific for imaging myocardial inflammation nor the 
infiltration of the inflammatory cells itself.  
Molecular imaging may be useful for visualizing 
active myocardial inflammation or infiltration of 
inflammatory cells. Specifically, macrophages are 
major effector cells in myocarditis (1) and 
development of macrophage-specific tracers may aid 
in the diagnosis of myocarditis, the follow-up of the 
inflammatory status noninvasively and furthermore, 
development of new treatment strategies (6). In this 
work, we hypothesized that it would be possible to 
image myocardial inflammation using a novel 
positron-emitting agent, 68Ga-2-(p-isothiocyanato-
benzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid 
(NOTA) mannosylated human serum albumin (MSA), 
that we initially described as a lymph node imaging 
agent (7).  
Materials and Methods 
Synthesis of 68Ga-NOTA-MSA 
A detailed description of the synthesis process 
and the labeling efficiencies, radiochemical purities 
have been published elsewhere (7). NOTA-MSA was 
synthesized following two steps; 1) Conjugation of 
α-D-mannopyranosylphenyl isothiocyanate to human 
serum albumin (HSA), resulting in MSA. 2) 
Conjugation of MSA from the first step with 
(p-SCN-Bn)-NOTA, resulting in NOTA-MSA. MSA 
was synthesized by conjugating 20mg HSA 
(Sigma-Aldrich, St. Louis, MO, USA) with 5.5mg 
SCN-mannose (Sigma-Aldrich) in 0.1M sodium 
carbonate buffer (pH 9.5) for 20 hours. The MSA was 
again conjugated with 10mg 2-(p-isothiocyanato-
benzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid 
(SCN-NOTA) in the same buffer for 2 hours. 1mg 
NOTA-MSA in 1mL normal saline was mixed with 
1mL 68GaCl3 (in 0.1N HCl) (68Ge/68Ga generator from 
Eckert & Ziegler, Berlin, Germany) to generate the 
final product, 68Ga-NOTA-MSA. 
Animal models of myocarditis 
Protocols of animal studies were approved by 
the institutional animal care and use committee and 
experiments using the radioactive tracers were 
approved by the institutional biosafety committee of 
Seoul National University Hospital. Quantitations of 
echocardiography and positron emission tomography 
(PET) images were done in a blinded manner.  
A mixture of 1mg (10mg/mL) porcine cardiac 
myosin (Sigma-Aldrich, St. Louis, MO, USA) with an 
equal volume of complete Freund’s adjuvant 
(Sigma-Aldrich) was injected into the footpad 
subcutaneously at days 1 and 8 in 7-week old male 
Lewis rats (Orient Bio, Seongnam-si, Gyeonggi-do, 
Korea) (8,9). Cyclosporine-A (Sigma-Aldrich) was 
given intraperitoneally daily (5mg/kg) starting from 
the indicated day for treatment of myocarditis. 
Transthoracic echocardiography (Nemio, Toshiba Co., 
Tokyo, Japan) was performed weekly starting from 
day 1. The animals were anesthetized using the lowest 
dose of isoflurane (4% initially and then 2~3% for 
maintenance) as possible with mixed oxygen. The left 
ventricular (LV) wall thickness at end-diastole, LV 
end-diastolic/systolic dimensions (LVEDD/LVESD) 
was measured at the papillary muscle level using the 
M-mode echocardiography. The LV fractional 
shortening was calculated as (LVEDD-LVESD)/ 
LVEDD. Animals were sacrificed at day 22 after 
taking the 68Ga-NOTA-MSA PET. The 
68Ga-NOTA-MSA uptake in each organ was measured 
by the radioactivity of each organ using an automated 
γ-counter (Cobra II, Packard Instruments, Meriden, 
CT) 1 hour post-injection and the results expressed as 
standard uptake value (SUV). SUV was calculated as 
(decay-corrected activity/unit tissue weight)/ 
(injected activity/body weight). 
PET/CT imaging and analysis 
The 68Ga-NOTA-MSA radioactive tracer (55.5 
MBq) was injected via tail vein and dynamic images 
were acquired for 60 minutes’ post-injection with a 
dedicated PET/CT scanner (eXplore VISTA, GE 
Healthcare, WI, USA). After confirming that the 
distribution of 68Ga-NOTA-MSA reached 
pseudoequilibrium 40 minutes’ post-injection (Figure 
1), a 20 minute static image was acquired at 40~60 
minutes post-injection. The PET scans were 
performed and reconstructed as previously described 
(10). In brief, the scan images were reconstructed 
using a 3-dimensional ordered-subsets expectation 
maximum algorithm with random and scatter 
corrections. Attenuation correction was done using 
corresponding CT scan. The voxel size was 
0.3875×0.3875×0.775 mm. For autoradiography, the 
heart was sectioned into 20µm thick short-axis slices 
and exposed to a radiosensitive image plate (11). FLA 
2000 system (Fuji, Tokyo, Japan) was used for the 
autoradiography experiment. 
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Figure 1. Distribution pattern of 68Ga-NOTA-MSA according to time in 
various organs or tissues. LV, left ventricle; RV, right ventricle; SUV, standard 
uptake value. 
 
The region of interest (ROI) templates were used 
for measuring uptake of LV and RV. The ROI 
templates were made using 11C-peripheral 
benzodiazepine receptor (PBR) images of the normal 
rat heart. The PBR, also known as translocator protein, 
is an avid protein that is highly expressed in the 
myocardium (12,13). We could clearly delineate LV 
and RV using the PET images of 11C-PBR, which is an 
established translocator protein imaging agent. 
Isocontour function using a threshold of 40% of 
maximal uptake was used to make template ROIs for 
LV and RV. The size and axis of the template ROIs 
were adjusted according to the outer contour of each 
rat’s heart based on its CT images. As there was a 
substantial spillover of the signal from the liver, we 
cautiously excluded the lower part of the LV or RV 
ROI that is overlaid by the liver uptake. The 
0.1cm3-sized spherical ROI was also drawn on the left 
paraspinal muscle at the level of upper T-spines to 
quantify the background tracer uptake. 
Average/maximal standardized uptake value (SUV) 
was defined as average/maximal SUV of total voxels 
in the ROIs. Maximal myocardium to paraspinal 
muscle SUV ratio (maximal SUVR) was defined as 
maximal SUV of the myocardium divided by maximal 
SUV of the paraspinal muscle. Average myocardium 
to paraspinal muscle SUV ratio (average SUVR) was 
defined as average SUV of the myocardium divided 
by average SUV of the paraspinal muscle. In 
experiments using unlabeled MSA for blockade of 
68Ga-NOTA-MSA binding in vivo, a 150-fold excess of 
unlabeled MSA was administered intravenously 10 
minutes prior to tracer injection. All image analysis 
and visualization were done using PMOD software 
(PMOD Technologies Ltd, Zurich, Switzerland).  
For the comparison of 68Ga-NOTA-MSA PET 
with 18F-fluorodeoxyglucose (18F-FDG) PET for 
imaging myocarditis, all rats were kept fasting for >15 
hours and the 18F-FDG (37 MBq) injected 
intraperitoneally. The images were acquired after 1 
hour of injecting the 18F-FDG. The analysis method 
was identical to that of the 68Ga-NOTA-MSA PET 
images. 
Flow cytometry of MSA uptake 
RAW 264.7 cells (ATCC, Manassas, VA) were 
cultured (DMEM supplemented with 5% fetal bovine 
serum) and the cells were incubated with 0.01mg/mL 
rhodamine isothiocyanate (RITC)-tagged HSA, 
RITC-MSA or 68Ga-NOTA-MSA for 1 hour. The signal 
intensity, count of the cells was analyzed using the 
flow cytometry machine (BD FACSCaliburTM, BD 
Biosciences, San Jose, CA) and program (BD 
FACSDivaTM, BD Biosciences) or an automated 
gamma counter (Cobra II 5003, Packard Bioscience, 
Meridien, CT). MSA binding was blocked with the 
indicated concentration of unlabeled MSA, 1 hour 
before incubation with RITC-MSA or 
68Ga-NOTA-MSA.  
Human studies 
Biopsy samples were obtained from 4 patients 
diagnosed with myocarditis and from 3 patients who 
underwent a routine endomyocardial biopsy after 
heart transplantation. The 3 heart transplantation 
patients did not have any symptoms or signs of 
rejection. The study was conducted in accordance 
with the latest Declaration of Helsinki and the 
institutional review board approved the study 
protocol. 
Immunohistochemical, immunofluorescent 
staining  
Myocardial specimens were fixed and the 
midventricular section was made into paraffin blocks. 
Primary antibodies used for immunohistochemistry 
were anti-ED-1 (EMD Millipore, Billerica, MA) for 
macrophages and anti-mannose receptor (MR) 
(Abcam, Cambridge, MA) for mannose receptor. 
These were incubated with appropriate secondary 
antibodies and visualized using the DAB substrate kit 
or secondary antibodies conjugated with the 
appropriate immunofluorescence reporter. For 
visualization of MSA uptake, RITC-MSA was given 
during the secondary antibody incubation step in the 
tissue section. All images were taken with either a 
slide scanner (Leica SCN400, Leica microsystems, 
Wetzlar, Germany) for the immunohistochemical 
specimens or a confocal microscopy (LSM 710, Carl 
Zeiss, Jena, Germany) for the immunofluorescent 
staining. 
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Statistical analyses  
All data are presented as median (together with 
the range where needed) and analyzed using the 
Mann-Whitney U-test. The degree of trend was tested 
using the extended Mantel-Haenszel Chi-square for 
linear trend. Graphs were drawn with GraphPad 
Prism 7.0 (GraphPad Software Inc., San Diego, CA). A 
two-tailed p-value<0.05 was considered statistically 
significant and all statistical analysis was done using 
the SPSS version 21.0 software (SPSS, Chicago, IL).  
Results 
Infiltration of MR-positive macrophages in 
myocarditis and the uptake of 
68Ga-NOTA-MSA by macrophages 
Human endomyocardial biopsy samples of 
myocarditis demonstrated extensive myocardial 
destruction with interstitial infiltration of 
inflammatory cells (Figure 2A). Immunohisto-
chemical MR staining demonstrated that a significant 
majority of these cells were MR-positive (Figure 2B). 
There were minimal inflammatory or MR-positive 
cells in the myocardial specimens taken from normal 
heart transplantation recipients. 
 
 
Figure 2. Infiltration of mannose receptor-positive macrophages in myocarditis. (A) Inflammatory cells infiltrated the myocardium significantly in human myocarditis 
sample (left panel) as compared to normal human myocardium in heart transplantation recipients (right panel). H&E staining. (B) Adjacent section of samples in Figure 2A 
identified a significant proportion of the inflammatory cells to be positive for mannose receptor (brown color) in human myocarditis (left panel) as compared to normal human 
myocardium (right panel). Representative mannose receptor immunostaining images. n=3~4 per group. (C) Inflammatory cells significantly infiltrated the myocardium in the rat 
myocarditis sample (left panel) as compared to minimal in the normal rat myocardium (right panel). Representative ED-1 immunostaining images. (D) RITC-MSA binds to 
mannose receptor-positive cells in rat myocarditis, which in turn are ED-1 positive. Red, MSA; green, mannose receptor (MR); white, ED-1; blue, DAPI. 
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We harvested the rat heart after 3 weeks of 
porcine cardiac myosin injection, the timepoint of 
maximal inflammation as in a previous report (8). 
Extensive ED-1-positive inflammatory cell infiltration 
was noted in the myocardium of the myocarditis rats 
(Figure 2C). The MSA distribution pattern colocalized 
to the areas positive for MR, suggesting that MSA 
uptake is associated with MR (Figure 2D). The cells 
positive for MR and for MSA binding ex vivo were 
positive for ED-1, suggesting that macrophages are 
the major cells responsible for MSA uptake.  
In vivo biodistribution of 68Ga-NOTA-MSA in 
rats under myocarditis 
We analyzed the pattern of 68Ga-NOTA-MSA 
distribution in control and myocarditis rats, 1 hour 
post-injection of the tracer after 3 weeks of 
inflammation. The biodistribution assay 
demonstrated significantly higher tracer uptake in the 
spleen, kidney and the heart in the myocarditis than 
the normal rats (Table 1). There was a 3.2-fold higher 
γ-emission from the myocardium of the myocarditis 
compared with that of the control rats (Figure 3), the 
degree of which was higher than any other organ.  
Table 1. Postmortem biodistribution of 68Ga-NOTA-MSA of 
each organ in normal control rats versus the myocarditis rats. 
 Normal (n=4, SUV) Myocarditis (n=6, SUV) p-value 
Blood 0.74 (0.74~0.76) 0.67 (0.19~0.82) 0.114 
Paraspinal muscle 0.05 (0.04~0.06) 0.05 (0.04~0.07) 0.746 
Lung 1.34 (1.13~1.57) 1.01 (1.00~1.75) 0.257 
Liver 19.64 (16.60~20.34) 19.82 (17.28~21.65) 0.762 
Spleen 8.72 (7.32~9.19) 12.20 (10.46~13.23) 0.010 
Intestine 0.06 (0.04~0.27) 0.15 (0.07~0.33) 0.114 
Kidney 0.72 (0.70~0.76) 0.87 (0.80~1.00) 0.010 
Bone marrow 2.04 (1.79~2.15) 2.17 (1.86~2.72) 0.352 
Heart 0.32 (0.31~0.33) 1.02 (0.86~1.06) 0.010 
All values presented as median (range). SUV, standard uptake value. 
 
 
 
Figure 3. Uptake of 68Ga-NOTA-MSA in the myocardium. Post-mortem 
biodistribution of 68Ga-NOTA-MSA in the myocardium of normal versus myocarditis 
rats, 1 hour post-injection of the tracer. Median values of each groups are shown as 
horizontal lines. SUV, standard uptake value. 
68Ga-NOTA-MSA for the diagnosis of 
myocardial inflammation in myocarditis 
Compared with the normal rats (Figure 4A and 
Supplementary Movie S1), the 68Ga-NOTA-MSA 
uptake in the myocardium was significantly higher in 
the myocarditis rats (Figure 4B and Supplementary 
Movie S2). The localization of ED-1-positive 
inflammatory cells overlapped with the 
68Ga-NOTA-MSA autoradiography (Figure 4C). 
Although the systolic function was not significantly 
different (Supplementary Figure S1A), the LV 
myocardium was significantly thicker in the 
myocarditis rats (Figure 4D). The average SUVR in 
both ventricles was significantly higher in the 
myocarditis rats (Figure 4E and 4F), as well as the 
maximal SUVR (Supplementary Figure S1B and S1C). 
There was no overlap in the degree of 
68Ga-NOTA-MSA uptake between the myocarditis 
versus the normal rats.  
Specificity of 68Ga-NOTA-MSA uptake for 
inflammatory cell imaging 
After confirming the colocalization of MSA 
binding and MR expression in the myocardium by 
tissue staining (Figure 2D), we further investigated 
the specificity of the tracer. A strong fluorescent signal 
shift was found in RITC-MSA treated RAW 264.7 
cells, indicating substantial tracer uptake by the cells, 
while a minimal shift was shown in 
non-mannosylated RITC-HSA treated cells (Figure 
5A). Furthermore, pretreatment with excess unlabeled 
MSA attenuated the signal in a dose-dependent 
manner (Figure 5B and 5C), confirming the specific 
uptake of RITC-MSA by a macrophage cell line. Also, 
similar findings were observed when 
68Ga-NOTA-MSA was used instead of RITC-MSA 
(data not shown). 
Interestingly, after administration of unlabeled 
MSA in the myocarditis rats, the uptake of 
68Ga-NOTA-MSA in the liver and the spleen, the 
major reticuloendothelial organs that harbor the 
inflammatory cells, were significantly attenuated to 
half or one-third. This was associated with significant 
increase of 68Ga-NOTA-MSA uptake in other organs, 
including the myocardium and the blood pool (Figure 
5D). However, the pattern of myocardial uptake in the 
myocarditis rats pretreated with unlabeled MSA was 
different from that in the myocarditis rats. Whereas 
the 68Ga-NOTA-MSA uptake was focally increased 
and associated with the sites of macrophage 
infiltration in the myocarditis rats, the uptake was 
diffusely enhanced and was not associated with the 
site of the macrophage infiltration in the myocarditis 
rats pretreated with unlabeled MSA (Figure 5E). 
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Figure 4. 68Ga-NOTA-MSA PET imaging for the diagnosis of myocardial inflammation in myocarditis rats. (A and B) Representative 68Ga-NOTA-MSA images 
and the corresponding ED-1 staining results for inflammatory cells (brown color) in normal (A) versus myocarditis (B) rats. Higher 68Ga-NOTA-MSA was noted in the 
myocarditis rats compared with the normal rats, which was corroborated by the massive infiltration of inflammatory cells in the immunohistochemistry. (C) The 
68Ga-NOTA-MSA uptake pattern in the myocardium by autoradiography colocalizes with the pattern of inflammatory cell infiltration by ED-1 immunostaining (brown color) in 
rat myocarditis. (D) Significantly thicker left ventricle (LV) wall in the myocarditis rats compared with the normal rats by M-mode echocardiography. (E and F) Significantly higher 
average 68Ga-NOTA-MSA uptake at the LV (E) and the right ventricle (RV) (F) in the myocarditis rats compared with the normal rats. The median value of each groups are shown 
as horizontal lines in (D), (E) and (F). SUV(R), standardized uptake value (ratio). 
 
68Ga-NOTA-MSA for monitoring the efficacy 
of myocarditis treatment 
Rats with myocarditis were treated with 
systemic cyclosporine-A after the initial dose of 
porcine cardiac myosin immunization (14). In contrast 
to the inflammatory cell infiltration in rats with 
myocarditis, rats co-treated with cyclosporine-A did 
not show any sign of inflammation in the 
myocardium (Figure 6A and 6B). Although there was 
no difference in the LV systolic function between both 
groups (Supplementary Figure S2A), co-treatment 
with cyclosporine-A significantly decreased the 
average LV wall thickness (Figure 6C). Average SUVR 
in both ventricles was significantly higher in the 
myocarditis rats compared with the cyclosporine-A 
co-treated rats (Figure 6D and 6E), as well as the 
maximal SUVR (Supplementary Figure S2B and S2C).  
To fully dissect the potential clinical benefit of 
68Ga-NOTA-MSA PET in the image-based 
identification of inflammation, we also investigated 
whether there would be changes in the degree of 
68Ga-NOTA-MSA uptake according to the treatment 
duration of cyclosporine-A. There was a decrease in 
the degree of 68Ga-NOTA-MSA uptake in the 
myocardium according to the treatment duration of 
cyclosporine-A (Figure 6F). This decreasing trend of 
68Ga-NOTA-MSA uptake was dependent on the 
duration of cyclosporine-A treatment (Figure 6G), 
suggesting that the 68Ga-NOTA-MSA PET may 
indeed be used for monitoring the response to 
treatment.  
Comparison of the efficacy of the 
68Ga-NOTA-MSA with 18F-FDG for 
myocarditis imaging 
As 18F-FDG is widely used for imaging of 
inflammation (15), we compared the efficacy of 
68Ga-NOTA-MSA to visualize the degree of 
inflammation with 18F-FDG in myocarditis. The 
PET/CT scans were taken from the identical set of rats 
using both 18F-FDG and 68Ga-NOTA-MSA. The 
hotspots of myocardial inflammation matched 
between the 18F-FDG and 68Ga-NOTA-MSA PET scans 
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in some animals (Figure 7A). However, despite the 
similar degree of inflammatory cell infiltration 
between the animals (Figure 7B), this was not 
accurately mirrored in the 18F-FDG PET images 
(Figure 7C). This was in contrast to the similar degree 
of the radioactive tracer uptake in the 
68Ga-NOTA-MSA PET scans (Figure 7D). 
Additionally, the extended fasting protocol was 
needed to suppress the normal uptake of glucose in 
the normal myocardium as suboptimal fasting of 
animals <8 hours resulted in nonspecific uptake of 
18F-FDG in the whole myocardium (data not shown). 
Taken together, the efficacy of 68Ga-NOTA-MSA PET 
was at least as effective as or even better than 18F-FDG 
PET. 
68Ga-NOTA-MSA for early detection of 
myocardial inflammation before structural 
changes in the myocardium 
Additionally, we tested whether 
68Ga-NOTA-MSA PET could be used for detection of 
myocardial inflammation before overt changes in the 
myocardium ensues, for example, myocardial edema. 
Clinically, it is difficult to demonstrate whether there 
is any myocardial inflammation by conventional 
imaging studies and demonstration of myocardial 
inflammation would be highly desirable for early 
diagnosis.  
All rats were followed with echocardiography 
and 68Ga-NOTA-MSA PET weekly. Although there 
were no signs of myocardial inflammation 2 weeks 
post-immunization of the initial dose of porcine 
cardiac myosin, a group of rats showed myocardial 
edema and pericardial effusion on echocardiography 
by 3 weeks post-immunization (Figure 8A). The 
average systolic function of the rats was not 
significantly different throughout the study. 
However, the rats demonstrated an increase of 
68Ga-NOTA-MSA uptake as early as 2 weeks 
post-immunization compared with the baseline 
images and the uptake was maintained at 3 weeks 
(Figure 8B). The 68Ga-NOTA-MSA uptake by week 2 
was significantly higher than the baseline level in all 
animals tested (Figure 8C).  
 
 
Figure 5. Specificity of 68Ga-NOTA-MSA uptake in myocarditis. (A) Mannosylation is needed for uptake of the tracer in RAW 264.7 cell line. (B and C) The degree of 
RITC-MSA uptake is decreased by pretreatment of cold, unlabeled MSA in a dose-dependent manner. (D) Compared with the myocarditis only rats, the 68Ga radiotracer signals 
in myocarditis rats pretreated with unlabeled MSA is decreased in the liver and the spleen, whereas the signal is significantly increased in other organs/tissues including the 
myocardium and the blood cavity. n=3 per group. SUV, mean standardized uptake value. (E) Autoradiography of the rat hearts demonstrate focally increased 68Ga-NOTA-MSA 
uptake in the myocarditis rats (upper right panel), whereas the signal was diffusely increased in general in the myocarditis rats pretreated with unlabeled MSA (lower right panel). 
However, the degree of myocardial inflammation is similar between the two representative rats (upper and lower left panels). EAM, experimental autoimmune myocarditis. 
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Figure 6. 68Ga-NOTA-MSA PET imaging for the follow-up of treatment efficacy in myocarditis rats. (A and B) Representative 68Ga-NOTA-MSA PET images and 
the corresponding ED-1 staining results for inflammatory cells (brown color) in the non-treated myocarditis rats (A) versus the myocarditis rats treated with cyclosporine-A (B). 
Higher 68Ga-NOTA-MSA uptake was noted in the non-treated myocarditis rats compared with the myocarditis rats treated with cyclosporine-A, which was supported by the 
infiltration of inflammatory cells in the immunohistochemistry. (C) Significant regression of the left ventricle (LV) hypertrophy/edema was noted in the myocarditis rats treated 
with cyclosporine-A compared with the non-treated myocarditis rats by M-mode echocardiography. (D and E) Significantly lower average 68Ga-NOTA-MSA uptake at the LV (D) 
and the right ventricle (RV) (E) in the myocarditis rats treated with cyclosporine-A compared with the non-treated myocarditis rats. The median value of each groups are shown 
as horizontal lines in (C), (D) and (E). (F) The uptake of 68Ga-NOTA-MSA decreases with the duration of cyclosporine-A treatment. (G) A significant trend is noted in the 
decrease of 68Ga-NOTA-MSA uptake with the increase in the duration of cyclosporine-A treatment. Cs-A, cyclosporine-A; SUV(R), standardized uptake value (ratio). 
 
Discussion 
In this study, we investigated the efficacy of a 
novel PET tracer, 68Ga-NOTA-MSA, as a potential 
pharmaceutical for the diagnosis and monitoring of 
myocarditis. The novel findings are: 1) 
68Ga-NOTA-MSA uptake is associated with the MR of 
the macrophages. 2) This characteristic of 
68Ga-NOTA-MSA, together with the infiltration of 
MR-positive macrophages, enables noninvasive 
diagnosis of myocarditis. 3) 68Ga-NOTA-MSA PET is 
effective for disease monitoring. 4) 68Ga-NOTA-MSA 
PET is useful for early diagnosis of myocarditis before 
myocardial edema ensues. Collectively, 
68Ga-NOTA-MSA PET enables noninvasive diagnosis 
and monitoring of myocardial inflammation in 
myocarditis. 
The MSA was initially developed for sentinel 
lymph node imaging as a single photon emission 
computed tomography agent by tagging the 99mTc 
(16,17) and revised recently for PET imaging agent (7). 
Mannose and human serum albumin are nontoxic, 
making it suitable for an optimal imaging agent. The 
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receptor of mannose residue is known to be expressed 
in M2 macrophages (18). A significant proportion of 
macrophages are positive for MR in rodent 
myocarditis models (1,19,20) and our staining results 
of human myocardial biopsy samples suggest that 
these cells may be significantly associated with the 
evolution of human myocarditis, thus providing a 
diagnostic basis of tracking MR-positive macrophages 
in myocarditis. Thinking of the potential benefit that 
albumin can be taken up by phagocytic cells and that 
68Ga-NOTA-MSA has 10~11 mannose residues in one 
albumin structure (7), we postulated that 
68Ga-NOTA-MSA would be an excellent molecule for 
imaging MR-positive macrophages. 
The clear difference of 68Ga-NOTA-MSA uptake 
between the normal and myocarditis rats demonstrate 
that PET imaging is useful for visualization of the 
degree of inflammation. Various imaging modalities 
such as echocardiography and cardiac magnetic 
resonance imaging are not specific for visualization of 
the cellular or molecular process. Previous 
investigators using PET have focused on 18F-FDG for 
the diagnosis of myocarditis (21-23). However, not 
only have the reports remained as case reports, the 
utility of 18F-FDG has not been supported by 
appropriate experimental studies. In our experiments, 
extensive fasting for >15 hours was needed to 
suppress the normal glucose uptake in the 
myocardium and the sensitivity of 18F-FDG to detect 
the inflammatory cell infiltration seemed to be lower 
than that of 68Ga-NOTA-MSA in some animals, 
questioning the sensitivity of 18F-FDG PET for 
imaging myocardial inflammation. Sugar 
monomer-based imaging depends on the transporter 
(24), the function and expression of which may 
change according to the tissue status itself. In contrast, 
MR, upon engagement by ligands, is shuttled to the 
endocytotic vesicle (25). Other tracers, such as iron 
oxide nanoparticles (9), are nonspecifically 
phagocytosed by any immune cells (26). Although 
radiolabeled albumin itself may be a potential 
candidate for inflammation imaging, previously 
published reports by our group and others (27,28) 
have verified that the blood pool uptake of the 
radioactive tracer is substantial at several hours after 
injection. This can delay optimal imaging time point 
and hamper accurate measurement of myocardial 
tracer uptake. On the contrary, 68Ga-NOTA-MSA 
showed rapid clearance from the blood pool which 
enabled us to image within 1 hour after the injection 
without the interference of blood pool uptake in our 
experiments (Figure 1). Therefore, the development of 
68Ga-NOTA-MSA PET for the diagnosis of 
myocarditis and the quantification of the degree of 
inflammation is potentially important for future 
clinical application and the mechanisms unique.  
 
 
Figure 7. Comparison of 18F-FDG and 68Ga-NOTA-MSA PET for detection of myocardial inflammation in myocarditis. (A) The hotspots of myocardial 
inflammation colocalizes between the 18F-FDG and 68Ga-NOTA-MSA PET scans in some animals. (B~D) Different degree of 18F-FDG and 68Ga-NOTA-MSA uptake in spite of the 
similar degree of inflammatory cell infiltration. (B) Similar degree of inflammatory cell infiltration on ED-1 immunostaining. (C) Different degree of 18F-FDG uptake between the 
animals, despite similar degree of inflammatory cell infiltration. (D) Similar degree of 68Ga-NOTA-MSA uptake between the animals, matching the pathology findings on Figure 7B. 
SUV, standardized uptake value. 
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Figure 8. Utility of 68Ga-NOTA-MSA PET for early detection of myocardial inflammation in myocarditis before structural changes in the myocardium. (A) 
Representative 2-dimensional echocardiography images of the left ventricular (LV) short-axis view at baseline, week 1, 2 and 3 after initiation of immunization. There was no 
difference in the LV wall thickness during this period. (B) Representative 68Ga-NOTA-MSA PET images of the same rat in Figure 8A at baseline, week 1, 2 and 3 
post-immunization. (C) Quantification of the 68Ga-NOTA-MSA on PET and LV wall thickness on echocardiography. Significant rise of the 68Ga-NOTA-MSA uptake is seen at 
week 2 on PET whereas the LV wall thickens at week 3 on echocardiography. The median value of each groups are shown as horizontal lines. SUV(R), standardized uptake value 
(ratio). 
 
Contrary to the dose-dependent decrease of 
MSA uptake in macrophage cell line in vitro, the 
pattern of tracer uptake was upregulated in the heart 
and downregulated in the reticuloendothelial system 
in animals injected with unlabeled precursor (Figure 
5). This kind of phenomenon has been used 
therapeutically in treating lymphoma patients with 
ibritumomab (Zevalin®), anti-CD20 antibody, where 
pretreatment with cold, unlabeled antibody is 
considered to enhance the binding of the labeled 
antibody to the cancer cells (29). Administration of the 
cold anti-CD20 antibody prior to the therapeutic 
antibodies emitting beta-radiation has shown to 
effectively block the vast reservoir of the antigens in 
 Theranostics 2017, Vol. 7, Issue 2 
 
 
http://www.thno.org 
423 
the bone marrow and spleen and therefore enhance 
the uptake of therapeutic antibodies to the lymphoma 
cells. Our results with the unlabeled MSA blockade 
are in agreement with these findings. Excess 
unlabeled MSA primarily blocked the labeled MSA 
uptake in major organs that serve as major reservoirs 
of inflammatory cells and prolonged the blood 
circulation of the labeled MSA. This may enhance the 
passive accumulation of the tracer in the myocardium 
and other organs (30,31). Furthermore, successful in 
vivo blockade of 68Ga-NOTA-MSA uptake to the 
macrophages in the myocardium could be supported 
by the autoradiography result after administration of 
excess unlabeled MSA, which showed diffusely 
increased uptake in the myocardium. 
Patients with myocarditis may not initially 
present with evidence of myocardial 
inflammation/edema and therefore, the diagnosis of 
myocarditis at an early stage of inflammation is 
clinically challenging (32). Although investigators 
have added the use of T2 magnetic resonance imaging 
for detection of myocardial edema (33), some have 
disputed its scientific basis (34). In a previous report 
using rat myocarditis model, abnormal magnetic 
resonance findings were not definite at 2 weeks after 
induction of myocarditis (35). In this respect, our 
findings showing clear 68Ga-NOTA-MSA uptake at 2 
weeks on PET after induction of myocarditis, which 
was earlier than myocardial edema on 
echocardiography, hold great promise for early 
diagnosis of these kinds of patients in doubt of 
diagnosis. Although earlier trials have failed to prove 
the efficacy of various immunosuppressive agents for 
myocarditis (36,37), this may be because myocarditis 
was diagnosed at a timepoint of ‘no-return’ (38,39). 
Additionally, the clear trend in the decrease of 
68Ga-NOTA-MSA uptake according to the duration of 
cyclosporine-A treatment suggests that 
68Ga-NOTA-MSA may be an effective tracer for 
monitoring the effect of treatment. 
There are some limitations of our study/tracer. 
First, our study does not prove whether 
68Ga-NOTA-MSA is specific to imaging myocarditis 
or whether it targets various diseases associated with 
MR-positive macrophage infiltration. We think it 
would be the latter based on the findings that 
68Ga-NOTA-MSA can be used for tracking the sentinel 
lymph node (7,16) and also imaging atherosclerosis 
(40). It would be clinically interesting to expand our 
findings to other cardiovascular diseases as the 
importance of MR-positive macrophages is 
highlighted in various previous papers. Second, our 
data does not show directly that the MR is the 
receptor of 68Ga-NOTA-MSA. However, albeit not the 
receptor of MSA, the pattern of colocalization of MR 
and MSA in the tissue sections suggests that MR is 
certainly a nodal mediator of MSA uptake in 
macrophages.  
In conclusion, we have shown that 
68Ga-NOTA-MSA is unique in showing the degree of 
myocardial inflammation in myocarditis. More 
specifically, the results of our study demonstrate the 
potential utility of visualizing MR-positive 
macrophages, using 68Ga-NOTA-MSA, in the 
diagnosis of myocarditis as well as in the follow-up of 
the efficacy of treatment or the disease course. Further 
studies in myocarditis patients, who suffer from the 
potentially fatal course of the disease, are warranted 
in the future for further expansion of this novel 
method.  
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